Captured Cells News Today

Parsortix test successful in discriminating malignant and benign abnormal pelvic masses from a simple blood draw for detection of ovarian cancerBest in class results indicate the potential to reduce both

According to a new study led by a Wilmot Cancer Institute physician/scientist, a new type of technology can collect stray ovarian cancer cells from a simple blood test and successfully forecast cancer in persons who have a lesion or cyst in the pelvic region.